In the last week, the United States market has been flat, but over the past 12 months, it has seen a 15% rise with earnings projected to grow by 17% annually. In this context of steady growth and positive forecasts, identifying stocks that are trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets.
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Symbotic (SYM) | $41.49 | $81.24 | 48.9% |
| Reddit (RDDT) | $179.23 | $354.32 | 49.4% |
| Rayonier (RYN) | $21.68 | $42.84 | 49.4% |
| Ouster (OUST) | $35.14 | $68.44 | 48.7% |
| Omada Health (OMDA) | $20.58 | $40.88 | 49.7% |
| Huntington Bancshares (HBAN) | $17.16 | $34.02 | 49.6% |
| Genuine Parts (GPC) | $127.70 | $245.88 | 48.1% |
| Dime Commercial Bancshares (DCOM) | $40.20 | $79.24 | 49.3% |
| Boeing (BA) | $211.50 | $417.72 | 49.4% |
| Bloom Energy (BE) | $188.18 | $374.94 | 49.8% |
Let's uncover some gems from our specialized screener.
Overview: VSE Corporation provides aviation aftermarket parts distribution and maintenance, repair, and overhaul services for air transportation assets in both commercial and government markets, with a market cap of $5.48 billion.
Operations: The company's revenue segment includes $1.18 billion from aviation aftermarket parts distribution and maintenance, repair, and overhaul services for air transportation assets in commercial and government sectors.
Estimated Discount To Fair Value: 48%
VSE Corporation is trading significantly below its estimated future cash flow value, with analysts agreeing on a potential stock price rise. Despite recent shareholder dilution and insider selling, VSE's earnings are projected to grow substantially, outpacing the US market. The company recently enhanced its credit facilities and reported strong first-quarter earnings with substantial revenue growth driven by acquisitions. However, future return on equity may remain modest despite the positive cash flow valuation.
Overview: American Healthcare REIT, Inc., a self-managed real estate investment trust based in Maryland, owns and operates a diversified portfolio of clinical healthcare properties across the U.S., U.K., and the Isle of Man, with a market cap of approximately $11.18 billion.
Operations: The company's revenue segments include Shop at $369.11 million, Outpatient Medical at $123.73 million, Triple-net Leased Properties at $39.47 million, and Integrated Senior Health Campuses contributing significantly with $1.84 billion.
Estimated Discount To Fair Value: 43.4%
American Healthcare REIT is trading significantly below its estimated future cash flow value, indicating potential undervaluation. Despite recent shareholder dilution and a lowered earnings forecast, the company's earnings are expected to grow substantially, surpassing US market averages. Recent executive changes aim to strengthen leadership amid these financial adjustments. The REIT's addition to the Russell Midcap Index highlights its evolving market presence despite being dropped from several other indices.
Overview: Modine Manufacturing Company designs, engineers, tests, manufactures, and sells mission-critical thermal solutions globally with a market cap of $12.84 billion.
Operations: The company's revenue is derived from its Climate Solutions segment, which generated $2.06 billion, and its Performance Technologies segment, which brought in $1.13 billion.
Estimated Discount To Fair Value: 11.5%
Modine Manufacturing is trading below its estimated future cash flow value of US$260.3, suggesting potential undervaluation. Despite a drop in profit margins and significant insider selling, the company's earnings are forecast to grow at 49.2% annually, outpacing the US market average. Recent strategic moves include a major agreement with a data center client and leadership changes in its Commercial HVAC segment, underscoring efforts to drive growth and operational efficiency.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com